IL15 and cancer: To understand if the effect observed previously in cancer cell death was solely mediated via non adherent PBMCs, or through the cancer cells, the former were preincubated with IL-15, ADU-S100 analog, or a combination of both for 24 h under optimal growth conditions and then washed before addition to the cancer cells for 48 h.